Device training (in-home or virtual) by an experienced nurse
Assist with understanding the insurance process
Arrange for the first NGENLA shipment from the pharmacy and address issues that may lead to pharmacy delays or treatment interruptions
Provide eligible, commercially insured patients with copay program enrollment
The program includes a Patient Care Consultant (PCC). They will work directly with your doctor, insurance, and pharmacy to help your child get started on NGENLA as soon as possible.
Once you and your child's doctor determine that NGENLA is the right treatment, the doctor will prescribe the therapy.
You and your child's doctor will then complete the Pfizer Bridge Program Enrollment Form. A PCC, who is part of the Pfizer Bridge Program, will contact you following your enrollment. Watch for a call from 1-800-645-1280.
Your child's doctor or the PCC will contact your insurance plan to confirm the growth hormone products available to your child and review the information with you.
Prescription drug plans (“plan”) often require your child's doctor to get approval or prior authorization before your child can be treated with NGENLA.
Your plan will review the information submitted by your child's doctor and either approve or deny your child's prescription. Your child's doctor or the PCC will contact you with the plan’s decision. If your child's prescription is denied, the Pfizer Bridge Program can provide information on appeals requirements.
A specialty pharmacy will send NGENLA directly to your home. Your PCC can share the specialty pharmacy information with you, assist with coordinating medication shipments, and help with any medication or device issues that may arise.
The Pfizer Bridge Program can help arrange in-home or virtual device training by an experienced nurse. View demonstration videos here. You can also contact the device support hotline at 1-800-645-1280 to speak with an experienced professional.
Plans may require your child to be reapproved to continue growth hormone treatment. Your PCC will contact you to ensure there is no lapse in your child's NGENLA treatment.
Be sure to attend all scheduled doctor's appointments to prevent any delays in reauthorization.
NGENLA has the broadest insurance coverage of any
once-weekly pGHD treatment in the United States.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
© 2024 Pfizer Inc. All rights reserved. PP-SMT-USA-0404
View mobile Terms and Conditions at engagedrx.com/pghd. Msg & Data rates may apply. Msg frequency varies. Text HELP for info, STOP to opt out. Pfizer’s Privacy Policy can be found at pfizer.com/privacy.
This confirms that you will soon be receiving weekly dosing reminders for NGENLA.